Friday, 16 October 2026European Markets

FRONTLINE, FLEX LNG, Another 1 Companies Have A High Dividend Yield And Return On Equity In The Energy Sector.

Loading stream...

(vianews) - frontline (fro.ol) is among this list of stock assets with the highest dividend rate and return on equity on the energy sector.

financial asset price forward dividend yield return on equity
frontline (fro.ol) kr152.18 12.91% 33.1%
flex lng (flng.ol) kr305.00 10.42% 16.76%
maurel et prom (mau.pa) €3.93 5.66% 26.41%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. frontline (fro.ol)

12.91% forward dividend yield and 33.1% return on equity

frontline plc, a shipping company, engages in the seaborne transportation of crude oil and oil products worldwide. it owns and operates oil and product tankers. as of december 31, 2022, the company operated a fleet of 70 vessels. it is also involved in the charter, purchase, and sale of vessels. the company was founded in 1985 and is based in limassol, cyprus.

earnings per share

as for profitability, frontline has a trailing twelve months eps of kr29.68.

pe ratio

frontline has a trailing twelve months price to earnings ratio of 5.13. meaning, the purchaser of the share is investing kr5.13 for every norwegian krone of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 33.1%.

more news about frontline.

2. flex lng (flng.ol)

10.42% forward dividend yield and 16.76% return on equity

flex lng ltd., together with its subsidiaries, engages in the seaborne transportation of liquefied natural gas (lng) worldwide. the company owns and operates vessels with m-type electronically controlled gas injection lng carriers; and vessels with generation x dual fuel propulsion systems. it also provides chartering services. flex lng ltd. was incorporated in 2006 and is based in hamilton, bermuda.

earnings per share

as for profitability, flex lng has a trailing twelve months eps of kr27.88.

pe ratio

flex lng has a trailing twelve months price to earnings ratio of 10.94. meaning, the purchaser of the share is investing kr10.94 for every norwegian krone of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 16.76%.

volume

today's last reported volume for flex lng is 8554 which is 72.68% below its average volume of 31311.

more news about flex lng.

3. maurel et prom (mau.pa)

5.66% forward dividend yield and 26.41% return on equity

etablissements maurel & prom s.a., an oil and gas exploration company, engages in the exploration and production of hydrocarbons. it operates through three segments: exploration, production, and drilling. the company was founded in 1831 and is headquartered in paris, france. etablissements maurel & prom s.a. is a subsidiary of pt pertamina internasional eksplorasi dan produksi.

earnings per share

as for profitability, maurel et prom has a trailing twelve months eps of €0.93.

pe ratio

maurel et prom has a trailing twelve months price to earnings ratio of 4.23. meaning, the purchaser of the share is investing €4.23 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 26.41%.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, maurel et prom's stock is considered to be oversold (<=20).

dividend yield

according to morningstar, inc., the next dividend payment is on jul 3, 2023, the estimated forward annual dividend rate is 0.23 and the estimated forward annual dividend yield is 5.66%.

more news about maurel et prom.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com